The WACC of Kinnate Biopharma Inc (KNTE) is 9.4%.
Range | Selected | |
Cost of equity | 13.00% - 17.00% | 15.00% |
Tax rate | 26.20% - 27.00% | 26.60% |
Cost of debt | 5.00% - 5.00% | 5.00% |
WACC | 8.4% - 10.3% | 9.4% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 2 | 2.17 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 13.00% | 17.00% |
Tax rate | 26.20% | 27.00% |
Debt/Equity ratio | 1 | 1 |
Cost of debt | 5.00% | 5.00% |
After-tax WACC | 8.4% | 10.3% |
Selected WACC | 9.4% | |